Last reviewed · How we verify

NCT04813874: NOLA

Nitrous Oxide and Neuraxial Labor Analgesia Use on Maternal Fetal Outcomes

Withdrawn Last updated 24 March 2021
What this trial tests

trial testing Nitrous Oxide in Pregnancy. Withdrawn.

Timeline
1 July 2016
Primary endpoint
1 July 2018
1 July 2018

Quick facts

Lead sponsorBrigham and Women's Hospital
StatusWithdrawn
Study typeOBSERVATIONAL
Start date1 July 2016
Primary completion1 July 2018
Estimated completion1 July 2018

Drugs / interventions tested

Conditions studied

Sponsor

Brigham and Women's Hospital

Who can join

18 and older, female only, with Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate maternal and neonatal outcomes in parturients who used nitrous oxide and neuraxial labor analgesia during labor.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Nitrous Oxide

Trials testing the same drug.

Other recruiting trials for Pregnancy

Currently open trials in the same condition.

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04813874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing